BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11837642)

  • 1. Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts.
    Hassell M; French MA
    Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):889-91. PubMed ID: 11837642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients.
    French MA; Mallal SA; Dawkins RL
    AIDS; 1992 Nov; 6(11):1293-7. PubMed ID: 1472334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection.
    Murray R; Mallal S; Heath C; French M
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):199-201. PubMed ID: 11347672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft tissue abscess and lymphadenitis due to Mycobacterium avium complex as an expression of immune reconstitution inflammatory syndrome after a second scheme of highly active antiretroviral therapy.
    Corti M; Villafañe MF; Ambroggi M; Sawicki M; Gancedo E
    Rev Inst Med Trop Sao Paulo; 2007; 49(4):267-70. PubMed ID: 17823760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
    Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
    Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.
    Aberg JA; Chin-Hong PV; McCutchan A; Koletar SL; Currier JS
    Clin Infect Dis; 2002 Jul; 35(1):E8-E13. PubMed ID: 12060894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.
    Lederman HM; Williams PL; Wu JW; Evans TG; Cohn SE; McCutchan JA; Koletar SL; Hafner R; Connick E; Valentine FT; McElrath MJ; Roberts NJ; Currier JS;
    J Infect Dis; 2003 Dec; 188(12):1794-803. PubMed ID: 14673757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycobacterium avium subcutaneous abscess and HIV infection].
    López-Isidro I; Santos-Gil I; Sanz-Sanz J
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):663-4. PubMed ID: 17194395
    [No Abstract]   [Full Text] [Related]  

  • 10. Late cerebral relapse of a Mycobacterium avium complex disseminated infection in an HIV-infected patient after cessation of antiretroviral therapy.
    Lascaux AS; Lesprit P; Deforges L; Gutierrez C; Lévy Y
    AIDS; 2003 Jun; 17(9):1410-1. PubMed ID: 12799571
    [No Abstract]   [Full Text] [Related]  

  • 11. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.
    Race EM; Adelson-Mitty J; Kriegel GR; Barlam TF; Reimann KA; Letvin NL; Japour AJ
    Lancet; 1998 Jan; 351(9098):252-5. PubMed ID: 9457095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
    Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
    Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia.
    Wendland T; Furrer H; Vernazza PL; Frutig K; Christen A; Matter L; Malinverni R; Pichler WJ
    AIDS; 1999 Oct; 13(14):1857-62. PubMed ID: 10513643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine.
    Mallal SA; James IR; French MA
    AIDS; 1994 Sep; 8(9):1263-9. PubMed ID: 7802978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastitis due to Mycobacterium avium complex in an HIV-infected woman taking highly active antiretroviral therapy.
    Cunningham CO; Selwyn PA
    AIDS Patient Care STDS; 2003 Nov; 17(11):547-50. PubMed ID: 14746662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
    Shafran SD; Mashinter LD; Phillips P; Lalonde RG; Gill MJ; Walmsley SL; Toma E; Conway B; Fong IW; Rachlis AR; Williams KE; Garber GE; Schlech WF; Smaill F; Pradier C
    Ann Intern Med; 2002 Nov; 137(9):734-7. PubMed ID: 12416943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
    Karakousis PC; Moore RD; Chaisson RE
    Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
    Lange CG; Woolley IJ; Brodt RH
    Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized Pulmonary Mycobacterium avium Disease in HIV-Infected Patients Without Access to HAART.
    Swaminathan S; Padmapriyadarsini C; Ramachandran R; Menon PA; Mohan NS; Kubendiran G; Paramasivan CN
    J Int Assoc Physicians AIDS Care (Chic); 2007 Dec; 6(4):264-8. PubMed ID: 17873247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.